Delivery Order SPE2DB20D1100-SPE2DB25FE1HT
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 28, 2025, by the Defense Logistics Agency (DLA) for the supply of Januvia 100 mg tablets (90-count units) valued at $2,182.92. This competitive award, which carries a firm fixed price and is not set-aside, is scheduled for completion by August 29, 2025, with performance to occur at the vendor's location in Conshohocken, Pennsylvania. The contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,487.16 by the Defense Logistics Agency on August 27, 2025, for the supply of Januvia 25 mg tablets (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999.13 fixed-price delivery order contract is for the supply of 4,568,090,529 units of the prescription medication Januvia 100 mg tablets. The contract has a period of performance through May 1, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,196.24 by the Defense Logistics Agency on August 21, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement with an ultimate completion date of August 22, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,356.27, is a delivery order to supply Januvia 100 mg tablets to the DLA. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,226.74 for 90 tablets of Januvia 100 mg, with an ultimate completion date of September 10, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Januvia 50 mg tablets in a quantity of 90 units, valued at $11,618.61. The contract was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and utilizes a firm fixed price structure with no set-aside designation. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,091.46 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Januvia 100 mg tablets (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 1,000 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract carries a ceiling value of $10,616.60 and was executed on May 30, 2025, with an ultimate completion date of June 2, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1HTDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $70,001.96 by the Defense Logistics Agency (DLA) on September 26, 2025, with an ultimate completion date of September 29, 2025. The delivery order covers the supply of Januvia 100 mg tablets in quantities of 90 units. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively procured with no set-aside designation and structured as a firm fixed-price contract, consistent with AmerisourceBergen's existing federal contracting relationships. This delivery order supports the federal healthcare supply chain, providing pharmaceutical products to military and veteran healthcare systems. AmerisourceBergen's DLA contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a diverse range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The firm fixed-price structure and competitive award demonstrate AmerisourceBergen's established capability to fulfill federal medical procurement requirements efficiently and cost-effectively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $70.0k | 9/26/25 |